Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2022-09-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-022-00736-z |
| _version_ | 1827905698521939968 |
|---|---|
| author | Franck Rapaport Kenneth Seier Yaseswini Neelamraju Duane Hassane Timour Baslan Daniel T. Gildea Samuel Haddox Tak Lee H. Moses Murdock Caroline Sheridan Alexis Thurmond Ling Wang Martin Carroll Larry D. Cripe Hugo Fernandez Christopher E. Mason Elisabeth Paietta Gail J. Roboz Zhuoxin Sun Martin S. Tallman Yanming Zhang Mithat Gönen Ross Levine Ari M. Melnick Maria Kleppe Francine E. Garrett-Bakelman |
| author_facet | Franck Rapaport Kenneth Seier Yaseswini Neelamraju Duane Hassane Timour Baslan Daniel T. Gildea Samuel Haddox Tak Lee H. Moses Murdock Caroline Sheridan Alexis Thurmond Ling Wang Martin Carroll Larry D. Cripe Hugo Fernandez Christopher E. Mason Elisabeth Paietta Gail J. Roboz Zhuoxin Sun Martin S. Tallman Yanming Zhang Mithat Gönen Ross Levine Ari M. Melnick Maria Kleppe Francine E. Garrett-Bakelman |
| author_sort | Franck Rapaport |
| collection | DOAJ |
| first_indexed | 2024-03-13T00:44:52Z |
| format | Article |
| id | doaj.art-bca00b52cde24e5bbb68655e6a010389 |
| institution | Directory Open Access Journal |
| issn | 2044-5385 |
| language | English |
| last_indexed | 2024-03-13T00:44:52Z |
| publishDate | 2022-09-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj.art-bca00b52cde24e5bbb68655e6a0103892023-07-09T11:06:52ZengNature Publishing GroupBlood Cancer Journal2044-53852022-09-011291510.1038/s41408-022-00736-zIntegrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999Franck Rapaport0Kenneth Seier1Yaseswini Neelamraju2Duane Hassane3Timour Baslan4Daniel T. Gildea5Samuel Haddox6Tak Lee7H. Moses Murdock8Caroline Sheridan9Alexis Thurmond10Ling Wang11Martin Carroll12Larry D. Cripe13Hugo Fernandez14Christopher E. Mason15Elisabeth Paietta16Gail J. Roboz17Zhuoxin Sun18Martin S. Tallman19Yanming Zhang20Mithat Gönen21Ross Levine22Ari M. Melnick23Maria Kleppe24Francine E. Garrett-Bakelman25Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer CenterDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer CenterDepartment of Biochemistry and Molecular Genetics, University of VirginiaDivision of Hematology and Medical Oncology, Department of Medicine, Weill Cornell MedicineCancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer CenterDepartment of Biochemistry and Molecular Genetics, University of VirginiaDepartment of Biochemistry and Molecular Genetics, University of VirginiaDivision of Hematology and Medical Oncology, Department of Medicine, Weill Cornell MedicineDivision of Hematology and Oncology, University of Pennsylvania Perelman School of MedicineDivision of Hematology and Medical Oncology, Department of Medicine, Weill Cornell MedicineDepartment of Biochemistry and Molecular Genetics, University of VirginiaDivision of Hematology and Medical Oncology, Department of Medicine, Weill Cornell MedicineDivision of Hematology and Oncology, University of Pennsylvania Perelman School of MedicineSimon Cancer Center, Indiana UniversityDepartment of Malignant Hematology & Cellular Therapy, Moffitt Cancer CenterDepartment of Physiology and Biophysics, Weill Cornell MedicineMontefiore Medical CenterWeill Cornell Medicine and The New York Presbyterian HospitalDana-Farber Cancer InstituteMemorial Sloan Kettering Cancer CenterDepartment of Pathology, Memorial Sloan Kettering Cancer CenterDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer CenterHuman Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer CenterDivision of Hematology and Medical Oncology, Department of Medicine, Weill Cornell MedicineHuman Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer CenterDepartment of Biochemistry and Molecular Genetics, University of Virginiahttps://doi.org/10.1038/s41408-022-00736-z |
| spellingShingle | Franck Rapaport Kenneth Seier Yaseswini Neelamraju Duane Hassane Timour Baslan Daniel T. Gildea Samuel Haddox Tak Lee H. Moses Murdock Caroline Sheridan Alexis Thurmond Ling Wang Martin Carroll Larry D. Cripe Hugo Fernandez Christopher E. Mason Elisabeth Paietta Gail J. Roboz Zhuoxin Sun Martin S. Tallman Yanming Zhang Mithat Gönen Ross Levine Ari M. Melnick Maria Kleppe Francine E. Garrett-Bakelman Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 Blood Cancer Journal |
| title | Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 |
| title_full | Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 |
| title_fullStr | Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 |
| title_full_unstemmed | Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 |
| title_short | Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 |
| title_sort | integrative analysis identifies an older female linked aml patient group with better risk in ecog acrin cancer research group s clinical trial e3999 |
| url | https://doi.org/10.1038/s41408-022-00736-z |
| work_keys_str_mv | AT franckrapaport integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT kennethseier integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT yaseswinineelamraju integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT duanehassane integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT timourbaslan integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT danieltgildea integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT samuelhaddox integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT taklee integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT hmosesmurdock integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT carolinesheridan integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT alexisthurmond integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT lingwang integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT martincarroll integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT larrydcripe integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT hugofernandez integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT christopheremason integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT elisabethpaietta integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT gailjroboz integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT zhuoxinsun integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT martinstallman integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT yanmingzhang integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT mithatgonen integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT rosslevine integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT arimmelnick integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT mariakleppe integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 AT francineegarrettbakelman integrativeanalysisidentifiesanolderfemalelinkedamlpatientgroupwithbetterriskinecogacrincancerresearchgroupsclinicaltriale3999 |